Search Results - "KREISEL, W."

Refine Results
  1. 1

    Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients by Kreisel, W, Dahlberg, M, Bertz, H, Harder, J, Potthoff, K, Deibert, P, Schmitt-Graeff, A, Finke, J

    Published in Bone marrow transplantation (Basingstoke) (01-03-2012)
    “…Diagnosis of acute intestinal GVHD (aGVHD) following allogeneic hematopoietic cell transplantation is based on clinical symptoms and histological lesions. This…”
    Get full text
    Journal Article
  2. 2

    Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation by Hasselblatt, P., Drognitz, K., Potthoff, K., Bertz, H., Kruis, W., Schmidt, C., Stallmach, A., Schmitt-Graeff, A., Finke, J., Kreisel, W.

    Published in Alimentary pharmacology & therapeutics (01-10-2012)
    “…Summary Background Despite advances in immunosuppressive therapy, up to 10% of patients with severe Crohn's disease (CD) remain refractory to conventional…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients by Ally, R., Schürmann, D., Kreisel, W., Carosi, G., Aguirrebengoa, K., Dupont, B., Hodges, M., Troke, P., Romero, A. J.

    Published in Clinical infectious diseases (01-11-2001)
    “…The efficacy, safety, and tolerability of voriconazole and fluconazole were compared in 391 immunocompromised patients with mycology- and biopsy-proven…”
    Get full text
    Journal Article
  5. 5

    Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation by KREISEL, W, POTTHOFF, K, BERTZ, H, SCHMITT-GRAEFF, A, RUF, G, RASENACK, J, FINKE, J

    Published in Bone marrow transplantation (Basingstoke) (01-08-2003)
    “…In a 36-year-old male with ileocolic Crohn's disease (CD) no long-lasting remission was obtained by treatment with corticosteroids, mesalazine, azathioprine…”
    Get full text
    Journal Article
  6. 6

    Budesonide in previously untreated autoimmune hepatitis by Wiegand, Johannes, Schüler, Andreas, Kanzler, Stephan, Lohse, Ansgar, Beuers, Ulrich, Kreisel, Wolfgang, Spengler, Ulrich, Koletzko, Sibylle, Jansen, Peter L. M., Hochhaus, Günther, Möllmann, Helmut W., Pröls, Markus, Manns, Michael P.

    Published in Liver international (01-10-2005)
    “…: Background: Autoimmune hepatitis (AIH) is a chronic liver disease that is effectively treated with immunosuppressive therapy. Predniso(lo)ne, often in…”
    Get full text
    Journal Article
  7. 7

    Effect of vardenafil, an inhibitor of phosphodiesterase‐5, on portal haemodynamics in normal and cirrhotic liver – results of a pilot study by DEIBERT, P., SCHUMACHER, Y.‐O., RUECKER, G., OPITZ, O. G., BLUM, H. E., RÖSSLE, M., KREISEL, W.

    Published in Alimentary pharmacology & therapeutics (01-01-2006)
    “…Summary Background  Dysregulation of the cyclic guanosine 3′,5′ monophosphate–nitric oxide system is in part responsible for portal hypertension in cirrhosis…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A clinical trial on absorption and N-acetylation of oral and rectal mesalazine by Dilger, K., Trenk, D., Rössle, M., Cap, M., Zähringer, A., Wacheck, V., Remmler, C., Cascorbi, I., Kreisel, W., Novacek, G.

    Published in European journal of clinical investigation (01-07-2007)
    “…Background  Mesalazine (5‐ASA) is a standard treatment for ulcerative colitis. Extent of absorption and N‐acetylation determine systemic exposure to 5‐ASA, and…”
    Get full text
    Journal Article
  10. 10

    6‐Thioguanine — efficacy and safety in chronic active Crohn's disease by Herrlinger, K. R., Kreisel, W., Schwab, M., Schoelmerich, J., Fleig, W. E., Ruhl, A., Reinshagen, M., Deibert, P., Fellermann, K., Greinwald, R., Stange, E. F.

    Published in Alimentary pharmacology & therapeutics (15-02-2003)
    “…Summary Background : Azathioprine and mercaptopurine are commonly used in chronic active Crohn's disease. They share the disadvantage of a delayed onset of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Remission maintenance by tioguanine in chronic active Crohn's disease by Herrlinger, K. R., Deibert, P., Schwab, M., Kreisel, W., Fischer, C., Fellermann, K., Stange, E. F.

    Published in Alimentary pharmacology & therapeutics (15-06-2003)
    “…Summary Background: Tioguanine may offer an alternative for immunosuppression in chronic active Crohn's disease. Recently, we have shown that tioguanine is…”
    Get full text
    Journal Article
  13. 13

    Thioguanine‐nucleotides do not predict efficacy of tioguanine in Crohn's disease by Herrlinger, K. R., Fellermann, K., Fischer, C., Kreisel, W., Deibert, P., Schoelmerich, J., Fleig, W. E., Ruhl, A., Reinshagen, M., Greinwald, R., Stange, E. F., Schwab, M.

    Published in Alimentary pharmacology & therapeutics (15-06-2004)
    “…Summary Background : 6‐Thioguanine‐nucleotides seem to be the active metabolites of thiopurine therapy, and their monitoring has been considered a useful tool…”
    Get full text
    Journal Article
  14. 14

    High variation of tioguanine absorption in patients with chronic active Crohn's disease by Deibert, P., Dilger, K., Fischer, C., Hofmann, U., Nauck, S., Stoelben, S., Kreisel, W.

    Published in Alimentary pharmacology & therapeutics (15-07-2003)
    “…Summary Background : Tioguanine (thioguanine) has been suggested as a therapeutic alternative for patients with Crohn's disease resistant or intolerant to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Severe lymphopenia in a patient with Crohn's disease by Monasterio, C, Kreisel, W, Hasselblatt, P

    Published in Der Internist (Berlin) (01-08-2018)
    “…We report on a 25-year-old female patient with Crohn's disease and profound lymphocytopenia while receiving corticosteroids and azathioprine. Discontinuation…”
    Get full text
    Journal Article
  17. 17

    Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD by BERTZ, H, AFTING, M, KREISEL, W, DUFFNER, U, GREINWALD, R, FINKE, J

    Published in Bone marrow transplantation (Basingstoke) (01-12-1999)
    “…Therapy of acute intestinal GVHD is still one of the main challenges after allogeneic transplantation. Increasing systemic immunosuppression (IS) is the first…”
    Get full text
    Journal Article
  18. 18

    International program on the health effects of the Chernobyl accident by Kreisel, W

    Published in Stem cells (Dayton, Ohio) (01-05-1995)
    “…The International Program on the Health Effects of the Chernobyl Accident (IPHECA) was established by the World Health Organization (WHO) in 1991. Currently,…”
    Get more information
    Journal Article
  19. 19

    High Prevalence of Antibodies to Calreticulin of the IgA Class in Primary Biliary Cirrhosis: a Possible Role of Gut-Derived Bacterial Antigens in Its Aetiology? by KREISEL, W, SIEGEL, A, BAHLER, A, SPAMER, C, SCHILTZ, E, KIST, M, SEILNACHT, G, KLEIN, R, BERG, P. A, HEILMANN, C

    “…Background: In a preliminary study we showed that antibodies to the endoplasmic reticulum protein calreticulin (CR) occur in primary biliary cirrhosis (PBC)…”
    Get full text
    Journal Article
  20. 20

    Water Quality and Health by Kreisel, W

    Published in Water science and technology (01-01-1991)
    “…Water quality can affect human health in various ways: through breeding of vectors, presence of pathogenic protozoa, helminths, bacteria and viruses, or…”
    Get full text
    Journal Article